FibroGen (FGEN) – Hot Corp. News
-
FibroGen (FGEN) Announces Positive Phase 3 Pooled Roxadustat Safety and Efficacy Results for Treatment of Anemia in Chronic Kidney Disease
-
FibroGen (FGEN) Reports China FDA Acceptance of Roxadustat New Drug Application (NDA)
-
-
-
-
-
Back to FGEN Stock Lookup